Peptide of the Week: The Truth About GLPs and What’s Coming Next with JAY CAMPBELL

Medical Disclaimer: We are not doctors. The content in this video is for educational and informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Any compounds discussed may be intended for research purposes only. Use at your own risk.

Welcome back, warriors! In this episode of Peptide of the Week, JD Denham and William T. Haas sit down with Jay Campbell to break down the truth about GLP peptides, what’s really happening behind the scenes, and where the future of fat loss and performance is heading.

From semaglutide to retatrutide and beyond this episode cuts through the noise and gives you real insight into how these compounds actually work and how most people are using them wrong.

Chapters:

00:00 – Intro & Jay Campbell Joins

03:33 – Peptide Sciences Shutdown Explained

08:10 – Big Pharma Pressure & Market Control

14:34 – GLP-1 Monopoly, FDA & Market Shift

18:39 – Fake Peptides & Bad Actors

23:20 – New Regulations & Testing Standards

27:21 – Compounding Pharmacies Under Attack

33:33 – MedV, AI Doctors & Affiliate Risk

39:33 – What’s Coming Next in Peptides

45:22 – FLGR-242 & Clotho Breakdown

55:35 – Nootropics & Cognitive Peptides

58:13 – If He Could Only Take One Peptide

1:19:18 – Live Event Plans & Final Plug

We cover:

🧬 GLP-1 Basics (Semaglutide & Tirzepatide)

– Designed for blood sugar regulation + appetite control

– Slows gastric emptying → keeps you fuller longer

– Improves insulin sensitivity

– Best for:

• Fat loss

• Appetite control

• Metabolic health

🔥 The Problem With Most Users

– 95% of people misuse GLPs

– No focus on protein intake

– No resistance training

– No hormone optimization

– Result:

• Muscle loss

• Slowed metabolism

• Poor long-term results

⚠️ Reality Check

– GLPs are NOT magic

– Without proper nutrition + training → you get skinny fat

– Education is the missing piece for most users

🚀 Retatrutide (Next-Level GLP)

– Triple agonist (GLP-1, GIP, Glucagon)

– Significantly stronger than semaglutide

– Increases fat loss AND metabolic output

– Potential to outperform all current fat loss drugs

– Future direction of the industry

💥 What’s Coming Next (Pipeline)

– Stage 4: Adds myostatin inhibition (muscle growth potential)

– Stage 5: Increases metabolic rate even at rest

– Future compounds may combine:

• Fat loss

• Muscle growth

• Metabolic enhancement

💪 Real Performance Insight

– GLPs should be paired with:

• High protein diet

• Strength training

• Proper recovery

– Microdosing can reduce side effects and improve sustainability

⚙️ Industry Truth

– Big pharma controls the GLP space

– Pricing and access will continue to be a major issue

– Research space is evolving rapidly

– Quality control and education will separate real results from scams

Follow us on social media:

JD's Instagram: https://www.instagram.com/jd_denham_fit

Will's Instagram: https://www.instagram.com/williamthaas/

Warrior-Makers Community: https://www.skool.com/warrior-makers/about

Jay Campbell’s Website: https://jaycampbell.com/

Jay’s Instagram: https://www.instagram.com/jaycampbell333

Jay’s X (Twitter): https://www.instagram.com/jaycampbell1971